Previous studies have suggested that certain cases of idiopathic central hypothyroidism of hypothalamic origin may result from the secretion of biologically inactive thyrotropin. To investigate this possibility and to define the mechanism of defective hormone action, we measured the adenylate cyclase-stimulating bioactivity (B) and receptor-binding (R) activity of purified immunoreactive serum thyrotropin (I) from seven patients with hypothalamic hypothyroidism. We found a strikingly decreased R/I ratio (less than 0.15) in patients as compared with controls (0.6 to 2.7) and a similarly decreased B/I ratio (less than 0.2 vs 2.8 to 5.6). After acute injection of thyrotropin-releasing hormone (TRH, 200 micrograms intravenously), the R/I ratio increased in two of three patients, but the B/I ratio became normal in only one. After administration of TRH for 20 to 30 days, an increase in immunoreactive serum thyrotropin was observed in all patients. Moreover, both ratios returned to normal in all but one patient, who had apparent desensitization. The increase in the amount and bioactivity of secreted thyrotropin after long-term TRH therapy resulted in enhanced secretion of serum thyroid hormones in all patients studied. We conclude that in certain cases of hypothalamic hypothyroidism, secreted thyrotropin lacks biologic activity because of impaired binding to its receptor; TRH treatment can correct both defects. These data suggest that TRH regulates not only the secretion of thyrotropin but also its specific molecular and conformational features required for hormone action.
This article has been cited by other articles:
Preiss, D., Todd, L., Panarelli, M.
(2008). Diagnosing unsuspected hypopituitarism in adults from suggestive thyroid function test results. Ann Clin Biochem
45: 70-75
[Abstract][Full Text]
Martins, M. R. A., Doin, F. C., Komatsu, W. R., Barros-Neto, T. L., Moises, V. A., Abucham, J.
(2007). Growth Hormone Replacement Improves Thyroxine Biological Effects: Implications for Management of Central Hypothyroidism. J. Clin. Endocrinol. Metab.
92: 4144-4153
[Abstract][Full Text]
Oliveira, J. H. A., Barbosa, E. R., Kasamatsu, T., Abucham, J.
(2007). Evidence for Thyroid Hormone as a Positive Regulator of Serum Thyrotropin Bioactivity. J. Clin. Endocrinol. Metab.
92: 3108-3113
[Abstract][Full Text]
Brabant, G, Beck-Peccoz, P, Jarzab, B, Laurberg, P, Orgiazzi, J, Szabolcs, I, Weetman, A P, Wiersinga, W M
(2006). Is there a need to redefine the upper normal limit of TSH?. Eur J Endocrinol
154: 633-637
[Abstract][Full Text]
Nikrodhanond, A. A., Ortiga-Carvalho, T. M., Shibusawa, N., Hashimoto, K., Liao, X. H., Refetoff, S., Yamada, M., Mori, M., Wondisford, F. E.
(2006). Dominant Role of Thyrotropin-releasing Hormone in the Hypothalamic-Pituitary-Thyroid Axis. J. Biol. Chem.
281: 5000-5007
[Abstract][Full Text]
Surks, M. I., Goswami, G., Daniels, G. H.
(2005). The Thyrotropin Reference Range Should Remain Unchanged. J. Clin. Endocrinol. Metab.
90: 5489-5496
[Abstract][Full Text]
Rabeler, R., Mittag, J., Geffers, L., Ruther, U., Leitges, M., Parlow, A. F., Visser, T. J., Bauer, K.
(2004). Generation of Thyrotropin-Releasing Hormone Receptor 1-Deficient Mice as an Animal Model of Central Hypothyroidism. Mol. Endocrinol.
18: 1450-1460
[Abstract][Full Text]
Surks, M. I., Ortiz, E., Daniels, G. H., Sawin, C. T., Col, N. F., Cobin, R. H., Franklyn, J. A., Hershman, J. M., Burman, K. D., Denke, M. A., Gorman, C., Cooper, R. S., Weissman, N. J.
(2004). Subclinical Thyroid Disease: Scientific Review and Guidelines for Diagnosis and Management. JAMA
291: 228-238
[Abstract][Full Text]
Mehta, A., Hindmarsh, P. C., Stanhope, R. G., Brain, C. E., Preece, M. A., Dattani, M. T.
(2003). Is the Thyrotropin-Releasing Hormone Test Necessary in the Diagnosis of Central Hypothyroidism in Children. J. Clin. Endocrinol. Metab.
88: 5696-5703
[Abstract][Full Text]
Moeller, L. C., Kimura, S., Kusakabe, T., Liao, X.-H., Van Sande, J., Refetoff, S.
(2003). Hypothyroidism in Thyroid Transcription Factor 1 Haploinsufficiency Is Caused by Reduced Expression of the Thyroid-Stimulating Hormone Receptor. Mol. Endocrinol.
17: 2295-2302
[Abstract][Full Text]
Krude, H., Biebermann, H., Schnabel, D., Tansek, M. Z., Theunissen, P., Mullis, P. E., Gruters, A.
(2003). Obesity Due to Proopiomelanocortin Deficiency: Three New Cases and Treatment Trials with Thyroid Hormone and ACTH4-10. J. Clin. Endocrinol. Metab.
88: 4633-4640
[Abstract][Full Text]
Fekete, C., Sarkar, S., Rand, W. M., Harney, J. W., Emerson, C. H., Bianco, A. C., Beck-Sickinger, A., Lechan, R. M.
(2002). Neuropeptide Y1 and Y5 Receptors Mediate the Effects of Neuropeptide Y on the Hypothalamic-Pituitary-Thyroid Axis. Endocrinology
143: 4513-4519
[Abstract][Full Text]
Fekete, C., Sarkar, S., Rand, W. M., Harney, J. W., Emerson, C. H., Bianco, A. C., Lechan, R. M.
(2002). Agouti-Related Protein (AGRP) Has a Central Inhibitory Action on the Hypothalamic-Pituitary-Thyroid (HPT) Axis; Comparisons between the Effect of AGRP and Neuropeptide Y on Energy Homeostasis and the HPT Axis. Endocrinology
143: 3846-3853
[Abstract][Full Text]
Kopp, P.
(2002). Perspective: Genetic Defects in the Etiology of Congenital Hypothyroidism. Endocrinology
143: 2019-2024
[Abstract][Full Text]
Szkudlinski, M. W., Fremont, V., Ronin, C., Weintraub, B. D.
(2002). Thyroid-Stimulating Hormone and Thyroid-Stimulating Hormone Receptor Structure-Function Relationships. Physiol. Rev.
82: 473-502
[Abstract][Full Text]
Bonomi, M., Proverbio, M. C., Weber, G., Chiumello, G., Beck-Peccoz, P., Persani, L.
(2001). Hyperplastic Pituitary Gland, High Serum Glycoprotein Hormone {{alpha}}-Subunit, and Variable Circulating Thyrotropin (TSH) Levels as Hallmark of Central Hypothyroidism due to Mutations of the TSH{beta} Gene. J. Clin. Endocrinol. Metab.
86: 1600-1604
[Abstract][Full Text]
Oliveira, J. H. A., Persani, L., Beck-Peccoz, P., Abucham, J.
(2001). Investigating the Paradox of Hypothyroidism and Increased Serum Thyrotropin (TSH) Levels in Sheehan's Syndrome: Characterization of TSH Carbohydrate Content and Bioactivity. J. Clin. Endocrinol. Metab.
86: 1694-1699
[Abstract][Full Text]
Persani, L., Ferretti, E., Borgato, S., Faglia, G., Beck-Peccoz, P.
(2000). Circulating Thyrotropin Bioactivity in Sporadic Central Hypothyroidism. J. Clin. Endocrinol. Metab.
85: 3631-3635
[Abstract][Full Text]
Shibusawa, N., Yamada, M., Hirato Tuyoshi Monden, J., Satoh, T., Mori, M.
(2000). Requirement of Thyrotropin-Releasing Hormone for the Postnatal Functions of Pituitary Thyrotrophs: Ontogeny Study of Congenital Tertiary Hypothyroidism in Mice. Mol. Endocrinol.
14: 137-146
[Abstract][Full Text]
Ferretti, E., Persani, L., Jaffrain-Rea, M.-L., Giambona, S., Tamburrano, G., Beck-Peccoz, P.
(1999). Evaluation of the Adequacy of Levothyroxine Replacement Therapy in Patients with Central Hypothyroidism. J. Clin. Endocrinol. Metab.
84: 924-929
[Abstract][Full Text]
Yamada, M., Saga, Y., Shibusawa, N., Hirato, J., Murakami, M., Iwasaki, T., Hashimoto, K., Satoh, T., Wakabayashi, K., Taketo, M. M., Mori, M.
(1997). Tertiary hypothyroidism and hyperglycemia in mice with targeted disruption of the thyrotropin-releasing hormone gene. Proc. Natl. Acad. Sci. USA
94: 10862-10867
[Abstract][Full Text]
Grossmann, M., Weintraub, B. D., Szkudlinski, M. W.
(1997). Novel Insights into the Molecular Mechanisms of Human Thyrotropin Action: Structural, Physiological, and Therapeutic Implications for the Glycoprotein Hormone Family. Endocr. Rev.
18: 476-501
[Abstract][Full Text]
Legradi, G., Emerson, C. H., Ahima, R. S., Flier, J. S., Lechan, R. M.
(1997). Leptin Prevents Fasting-Induced Suppression of Prothyrotropin-Releasing Hormone Messenger Ribonucleic Acid in Neurons of the Hypothalamic Paraventricular Nucleus. Endocrinology
138: 2569-2576
[Abstract][Full Text]
Surks, M. I., Sievert, R.
(1995). Drugs and Thyroid Function. NEJM
333: 1688-1694
[Full Text]
Previous
